Leviticus Cardio & Jarvik Heart unveil groundbreaking wireless heart pump system

Leviticus Cardio & Jarvik Heart unveil groundbreaking wireless heart pump system

Press releases may be edited for formatting or style | February 07, 2019 Cardiology Operating Room
PETAH TIKVA, Israel, Feb. 6, 2019 /PRNewswire/ -- A groundbreaking piece of medical technology was revealed to the public today at the National Research Center for Cardiac Surgery in Astana, Kazakhstan. At a press conference held at the Center, top heart failure experts from around the world announced the successful implantation of FIVAD (Fully Implanted Ventricular Assist Device) into a human.

A few hours before the press conference took place, an article about the FIVAD implantation was published by the prestigious Journal for Heart and Lung Transplantation (JHLT).

Among the guests from the medical community participating in the event; Professor Mandeep Mehra – Professor of Medicine - Harvard Medical School, and Editor-in-Chief of The Journal of Heart and Lung Transplantation as well as Professor Nir Uriel – Director, Heart Failure, Transplant and Mechanical Circulatory Support, University of Chicago and the Charmian of the Mechanical Circulatory support council at the International Society of Heart Lung Transplantation.

Servicing GE/Siemens Nuclear Medicine equipment with OEM trained engineers

Numed, a well established company in business since 1975 provides a wide range of service options including time & material service, PM only contracts, full service contracts, labor only contracts & system relocation. Call 800 96 Numed for more info.

FIVAD is based on technology created by Leviticus Cardio, a medical technology company headquartered in Israel. It uses patented Coplanar Energy Transfer (CET) to wirelessly power a heart pump – a Ventricular Assist Device (VAD). FIVAD incorporates a heart pump produced by Jarvik Heart Inc, an established manufacturer of ventricular assist devices.

Every year, VADs are surgically implanted into thousands of patients with severe heart failure in lieu of heart transplants. VADs need to continuously be connected to a power source which requires patients to have a wire coming out of their bodies. This not only severely reduces the patients' quality of life but, in over 20% of cases, causes infections which can lead to hospitalization and severe complications.

FIVAD is a fully implanted VAD system, a Jarvik 2000 pump, powered wirelessly using both internal and external components designed by Leviticus Cardio, which allows patients to walk around without any physical impediments for up to 8 hours a day.

After years of development and animal testing, the first implant of FIVAD in a human took place in December at the National Research Center for Cardiac Surgery in Astana, Kazakhstan. The operation was a success. The patient has been discharged from the hospital and is back leading a normal life. He was in the audience during the press conference and later sat down for interviews with journalists.

FIVAD is also equipped with a back-up system (Jarvik Heart, Post Auricular driveline connection) which would allow moving to traditional wired power in case the wireless system failed. While the back-up was tested during the implant procedure, it has not been needed since that initial implant test.

You Must Be Logged In To Post A Comment